# A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of AG2304T and AG2304R

> **NCT06717360** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Ahn-Gook Pharmaceuticals Co.,Ltd** · enrollment: 140 (estimated)

## Conditions studied

- Hypercholesterolemia

## Interventions

- **DRUG:** AG2304T
- **DRUG:** AG2304R

## Key facts

- **NCT ID:** NCT06717360
- **Lead sponsor:** Ahn-Gook Pharmaceuticals Co.,Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-06
- **Primary completion:** 2027-06
- **Final completion:** 2027-06
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2024-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06717360

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06717360, "A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of AG2304T and AG2304R". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT06717360. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*